Clinical pharmacology
A manifesto for clinical pharmacology from principles to practice
Dabigatran etexilate
Drug- and non-drug-associated QT interval prolongation
Eltrombopag does not affect cardiac repolarization
Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes
Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
Can finger-prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol?
Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase
Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder
Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidents
Oversight
Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis
Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects
The ‘apparent clearance’ of free phenytoin in elderly vs. younger adults
Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients
Teaching of clinical pharmacology and therapeutics in UK medical schools
Palonosetron induced anaphylaxis in an adult female
Biomarkers in Drug Development
Translation Section